R.H. Bluestein & Co’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$337K Hold
1,275
0.02% 212
2022
Q2
$266K Sell
1,275
-75
-6% -$16.7K 0.02% 278
2022
Q1
$299K Sell
1,350
-2,100
-61% -$444K 0.01% 292
2021
Q4
$807K Buy
3,450
+2,150
+165% +$532K 0.03% 129
2021
Q3
$285K Buy
+1,300
New +$278K 0.01% 332
2018
Q3
Sell
-2,500
Closed -$236K 316
2018
Q2
$236K Sell
2,500
-1,000
-29% -$96K 0.01% 279
2018
Q1
$325K Sell
3,500
-5,300
-60% -$584K 0.02% 229
2017
Q4
$1.13M Sell
8,800
-5,075
-37% -$688K 0.06% 70
2017
Q3
$1.89M Sell
13,875
-9,250
-40% -$1.1M 0.1% 57
2017
Q2
$2.44M Buy
23,125
+18,125
+363% +$1.97M 0.14% 51
2017
Q1
$528K Buy
+5,000
New +$487K 0.03% 131

Other funds holding ALB

R.H. Bluestein & Co's ALB Position: Q3 2022 in Review

R.H. Bluestein & Co held its Albemarle (ALB) position steady in Q3 2022 at 1,275 shares worth $337K. The position accounts for 0.02% of the portfolio, ranked #212.

R.H. Bluestein & Co first reported a position in ALB in Q1 2017 and has held it in 11 quarters since. The position peaked at $2.44M in Q2 2017. 966 funds tracked by Wall St. Rank hold ALB as of Q3 2022.

  • R.H. Bluestein & Co held 1,275 shares of Albemarle worth $337K as of Q3 2022.
  • R.H. Bluestein & Co left its Albemarle share count unchanged in Q3 2022.
  • Albemarle made up 0.02% of R.H. Bluestein & Co's portfolio in Q3 2022, its #212 holding.
  • R.H. Bluestein & Co first reported a position in Albemarle in Q1 2017 and has held it in 11 quarters since.
  • R.H. Bluestein & Co's Albemarle position peaked at $2.44M in Q2 2017.
  • 966 funds tracked by Wall St. Rank held Albemarle as of Q3 2022.

Based on R.H. Bluestein & Co's 13F filing for Q3 2022, filed 14 Nov 2022.